Indicated for: prevention and treatment of thromboembolism
Route of administration: oral
Substance: acenocoumarol (anticoagulant)
ATC: B01AA07 (Blood and blood forming organs | Antithrombotic agents | Vitamin K antagonists)
Acenocoumarol is an anticoagulant medication from the coumarin class, used for the prevention and treatment of thrombosis and embolism. It is indicated for conditions such as deep vein thrombosis, pulmonary embolism, atrial fibrillation, and the prevention of thromboembolic complications in patients with prosthetic heart valves.
Acenocoumarol works by inhibiting the synthesis of vitamin K-dependent clotting factors (factors II, VII, IX, and X), thereby reducing the blood's ability to form clots.
The dosage is individually adjusted based on regular monitoring of the INR (International Normalized Ratio) to maintain a balance between preventing clot formation and minimizing the risk of bleeding.
Common side effects include an increased risk of bleeding (e.g., nosebleeds, gum bleeding, or gastrointestinal bleeding), easy bruising, and, in rare cases, skin necrosis. Patients should avoid excessive consumption of foods rich in vitamin K (such as spinach, broccoli, or cabbage), as these can reduce the medication's effectiveness.
Acenocoumarol requires careful monitoring and frequent dose adjustments. Patients should inform their doctor about any other medications or supplements they are taking, as interactions can affect blood clotting.
Price
Copayment
Patient
8.82 RON
7.94 RON
0.88 RON
G1 (C1) - Chronic heart failure (NYHA class III or IV)
Price
Copayment
Patient
8.82 RON
8.82 RON
0.00 RON
G2 (C1) - Patients with valvular and vascular prostheses
Price
Copayment
Patient
8.82 RON
8.82 RON
0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
8.82 RON
8.82 RON
0.00 RON